Automate Your Wheel Strategy on TMO
With Tiblio's Option Bot, you can configure your own wheel strategy including TMO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMO
- Rev/Share 113.4868
- Book/Share 130.9153
- PB 3.2156
- Debt/Equity 0.6927
- CurrentRatio 1.7746
- ROIC 0.0771
- MktCap 158502180720.0
- FreeCF/Share 17.7884
- PFCF 23.5726
- PE 24.3614
- Debt/Assets 0.3452
- DivYield 0.0048
- ROE 0.1334
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | TMO | UBS | Buy | Neutral | -- | $460 | July 9, 2025 |
| Upgrade | TMO | Bernstein | Market Perform | Outperform | -- | $630 | Jan. 10, 2025 |
| Initiation | TMO | Scotiabank | -- | Sector Perform | -- | -- | Dec. 23, 2024 |
| Initiation | TMO | Redburn Atlantic | -- | Buy | -- | -- | Oct. 14, 2024 |
| Initiation | TMO | Stephens | -- | Overweight | -- | $680 | Oct. 1, 2024 |
| Initiation | TMO | Wells Fargo | -- | Overweight | -- | $670 | Aug. 28, 2024 |
News
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Negative
TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.
Read More
4 Of The Hottest Great American SWANs For The 4th Of July
Published: July 04, 2025 by: Seeking Alpha
Sentiment: Positive
I highlight four American SWAN stocks - Realty Income, Alphabet, Globe Life, and Thermo Fisher Scientific - offering stress-free, blue-chip investment opportunities. Each company boasts strong management, robust balance sheets, consistent earnings, and attractive valuations, trading 18-24% below my fair value estimates. These stocks offer a blended 1.8% yield, low payout ratios, and A or AA credit ratings, supporting reliable dividend growth and low long-term risk.
Read More
Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems
Published: June 23, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that it has been awarded a five-year, $94.5 million contract by the U.S. Department of Defense (DoD) to supply the Navy with a next-generation dosimetry system alongside updated radiation health and database management software. The U.S. Navy operates the world's most technologically advanced naval fleet and is the largest defense user of dosimetry systems globally. With this award, T.
Read More
Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business
Published: June 13, 2025 by: PYMNTS
Sentiment: Negative
Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research.
Read More
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
TMO grapples with macro pressures, rising expenses and fierce competition, but bets on acquisitions to fuel recovery.
Read More
TMO Launches Next-Generation Mass Spectrometers: Stock to Gain?
Published: June 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Thermo Fisher debuts two advanced MSs, Orbitrap Astral Zoom and Orbitrap Excedion Pro, to accelerate precision medicine and drug discovery breakthroughs.
Read More
Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research
Published: June 02, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer (MS) to help push the boundaries of scientific discovery. Delivering unrivaled analytical performance and speed, the instruments are designed to uncover complex biological processes that could lead to advancements in p.
Read More
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
Published: June 02, 2025 by: Seeking Alpha
Sentiment: Positive
The neutral DCF model implemented in this article suggests that Thermo Fisher is undervalued by 29.24%. Thermo Fisher has invested, on average, 16.51% of its revenues in capex between 2019 and 2024. Due to the significant investment in capex, Thermo Fisher's revenues have increased at a 12.95% CAGR between 2019 and 2024.
Read More
Thermo Fisher Is Strengthening Its Long-Term Advantage
Published: June 01, 2025 by: Seeking Alpha
Sentiment: Neutral
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary, not reflective of structural weakness in its fundamentals. The company is mitigating trade impacts by investing $2B in US manufacturing, leveraging diversification and innovation, and expects headwinds to peak this year. Biopharma growth, strategic acquisitions, and rapid product innovation position TMO for long-term outperformance versus less diversified peers.
Read More
TMO Stock Set to Gain From the Launch of New Narcotic Analyzers
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher launches new TruNarc analyzers to help law enforcement quickly detect 1,200+ substances, boosting field safety and drug interdiction efforts.
Read More
Why Is Thermo Fisher (TMO) Down 6.1% Since Last Earnings Report?
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Negative
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Read More
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ TruNarc™ Delta and Tau Handheld Narcotics Analyzers* to help communities combat known and emerging narcotics and illicit substances. With touchless technology and an expanded chemical library, the user-friendly devices empower frontline law enforcement officials to identify more than 1,200 substances in the field, including stimulants, depressants, hallucinogen.
Read More
10 Undervalued Dividend Growth Stocks: May 2025
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Positive
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.
Read More
3 Of The Cheapest High-Quality Stocks Money Can Buy
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Positive
Geopolitical risks and economic uncertainty have battered markets, but I view this turmoil as an opportunity to buy high-quality, undervalued stocks. Despite volatility and weak earnings trends, I'm focused on companies trading well below fair value, with strong fundamentals and long-term growth potential. In this article, I highlight three dirt-cheap stocks across different industries that I believe can deliver significant returns in the years ahead.
Read More
Thermo Fisher's Q1 Earnings Top Estimates, Revenues Beat, Stock Up
Published: April 23, 2025 by: Zacks Investment Research
Sentiment: Positive
TMO continues to advance its growth strategy and trusted partner status with customers in the first quarter of 2025.
Read More
Thermo Fisher Tops Q1 Estimates in 'Uncertain Macroeconomic Environment'
Published: April 23, 2025 by: Investopedia
Sentiment: Positive
Thermo Fisher Scientific (TMO) shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter results above analysts' expectations.
Read More
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript
Published: April 23, 2025 by: Seeking Alpha
Sentiment: Neutral
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief Executive Officer Stephen Williamson - Senior Vice President & Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Doug Schenkel - Wolfe Research Tycho Peterson - Jefferies Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 First Quarter Conference Call. [Operator Instructions] I would like …
Read More
Thermo Fisher Scientific And Its Real Value
Published: April 14, 2025 by: Seeking Alpha
Sentiment: Positive
Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a viable long-term investment. TMO's recent product expansion, including the breakthrough Krios 5 Cryo-TEM technology, is expected to drive future growth and support earnings. Valuation metrics indicate TMO is currently undervalued.
Read More
Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.
Read More
Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive
TMO and CZ Imaging Institute to collaborate on further understanding of human cells.
Read More
TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher introduces the Vulcan Automated Lab to transform semiconductor analysis.
Read More
Billionaire Investor Buys Stocks Despite Trump's ‘Unconventional Approach'
Published: March 06, 2025 by: 24/7 Wall Street
Sentiment: Positive
Daniel Loeb is a brilliant billionaire investor who's invested in all sorts of market environments.
Read More
Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion
Published: February 25, 2025 by: Reuters
Sentiment: Positive
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion.
Read More
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
Published: February 24, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 9:10 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader.
Read More
Final Trades: Exxon Mobil, Thermo Fisher and Cheniere Energy
Published: February 20, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
Thermo Fisher Scientific Elects New Director to Board
Published: February 19, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12. Ms. Lynch is a seasoned health care executive with over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS), a leading hea.
Read More
About Thermo Fisher Scientific Inc. (TMO)
- IPO Date 1980-03-17
- Website https://www.thermofisher.com
- Industry Medical - Diagnostics & Research
- CEO Marc N. Casper
- Employees 125000